|
Volumn 362, Issue 9398, 2003, Pages
|
The stain wars.
a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
FLUOROBENZENE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
PYRIMIDINE DERIVATIVE;
ROSUVASTATIN;
SULFONAMIDE;
CLINICAL TRIAL;
COMMERCIAL PHENOMENA;
CONTROLLED CLINICAL TRIAL;
DOSE RESPONSE;
DRUG ADMINISTRATION;
DRUG APPROVAL;
DRUG INDUSTRY;
ETHICS;
HUMAN;
HYPERLIPIDEMIA;
LEGAL ASPECT;
NOTE;
PATENT;
RANDOMIZED CONTROLLED TRIAL;
STANDARD;
STATISTICS;
MARKETING;
CANADA;
CLINICAL TRIALS;
COMMERCE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
DRUG APPROVAL;
DRUG INDUSTRY;
FLUOROBENZENES;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPERLIPIDEMIAS;
PATENTS;
PYRIMIDINES;
RANDOMIZED CONTROLLED TRIALS;
SULFONAMIDES;
MARKETING;
CANADA;
|
EID: 1542572131
PISSN: None
EISSN: 1474547X
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (1)
|
References (0)
|